Quick infos Headquarters: California, United States Trade prices Volume: Market Cap: 128.07M Prev closed: 2.45 Open: 2.26 High: 2.31 Low: 2.2 52 week low: 1.89 52 week high: 6.98 Dividends: No Dividends Next ER: May 9, 2022 After Market Closes
Company Profile Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière?s disease, hearing loss, and tinnitus.
Earnings History Date EPS / Forecast Revenue / Forecast August 4, 2022 May 9, 2022 -0.2 / -0.195- / -February 28, 2022 -0.2 / -0.1833- / -November 10, 2021 -0.19 / -0.185- / -August 4, 2021 -0.19 / -0.186735K / 41.67Kview more
Historical Data Date Price Open High Low Vol Change ER May 9, 2022 2.120 2.160 2.250
2.100
175.00K -4.5% May 6, 2022 2.220 2.250 2.260
2.130
57.06K -1.33% May 5, 2022 2.250 2.330 2.385
2.160
146.10K -8.54% May 4, 2022 2.460 2.490 2.490
2.242
169.44K -1.99% May 3, 2022 2.510 2.320 2.510
2.230
133.17K 9.61% May 2, 2022 2.290 2.180 2.320
2.124
52.67K 4.09% Apr 29, 2022 2.200 2.210 2.269
2.160
90.28K -1.35% Apr 28, 2022 2.230 2.230 2.290
2.160
63.57K 0% Apr 27, 2022 2.230 2.140 2.400
2.100
136.70K 2.76% Apr 26, 2022 2.170 2.260 2.300
2.130
99.93K -3.98% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Otonomy Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares investors.otonomy.com Jul 14, 2020 4:01 am Otonomy Announces Pricing of $60.1 Million Public Offering investors.otonomy.com Jul 9, 2020 9:00 pm Otonomy Announces Proposed Public Offering investors.otonomy.com Jul 9, 2020 4:03 am
Otonomy Reports Third Quarter 2020 Financial Results and Provides Corporate Update finance.yahoo.com Apr 9, 2021 4:17 pm
Otonomy, Inc. to Host Earnings Call finance.yahoo.com Apr 9, 2021 2:30 pm Otonomy stock loses half its value after disappointing trial results of vertigo treatment marketwatch.com Apr 9, 2021 8:37 am
Otonomy Announces Top-Line Results for the Phase 3 Clinical Trial of OTIVIDEX® in Patients with Ménière's Disease finance.yahoo.com Apr 9, 2021 7:00 am
Is Otonomy (NASDAQ:OTIC) Weighed On By Its Debt Load? finance.yahoo.com Apr 9, 2021 4:22 am Otonomy (OTIC) Stock Slides After Pricing Offering investorsobserver.com Apr 9, 2021 1:22 am The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For ... benzinga.com Apr 8, 2021 8:22 pm Here is why Otonomy Inc. (OTIC) Stock sunk on Tuesday, April 7, 2021 parktelegraph.com Apr 8, 2021 3:22 pm Otonomy raises $30M capital via equity offering seekingalpha.com Apr 8, 2021 1:43 pm Otonomy Announces Pricing of $30.1 Million Public Offering globenewswire.com Apr 8, 2021 11:22 am Otonomy shares drop 9% as company proposes capital raise (updated) seekingalpha.com Apr 8, 2021 4:12 am
Otonomy Announces Pricing of $30.1 Million Public Offering finance.yahoo.com Apr 7, 2021 10:02 pm What Kind Of Shareholders Hold The Majority In Otonomy, Inc ... simplywall.st Apr 2, 2021 11:22 am What is Wall Street's Target Price for Otonomy Inc (OTIC) Stock Wednesday? investorsobserver.com Apr 2, 2021 11:22 am Otonomy starts mid-stage trial of OTO-313 in tinnitus seekingalpha.com Mar 25, 2021 8:01 pm This company doesn't provide a dividend.
Talk about Otonomy below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.
